DUCRESSA

This brand name is authorized in Austria, Estonia, Spain, Finland, Croatia, Ireland, Lithuania, Poland, Romania

Active ingredients

The drug DUCRESSA contains a combination of these active pharmaceutical ingredients (APIs):

1 Dexamethasone disodium phosphate UNII AI9376Y64P - DEXAMETHASONE SODIUM PHOSPHATE

Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response. Read about Dexamethasone

2 Levofloxacin hemihydrate UNII 6GNT3Y5LMF - LEVOFLOXACIN

Levofloxacin is a synthetic antibacterial agent of the fluoroquinolone class. As a fluoroquinolone antibacterial agent, levofloxacin acts on the DNA – DNA-gyrase complex and topoisomerase IV. Read about Levofloxacin

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01CA01	Dexamethasone and antiinfectives	S Sensory organs → S01 Ophthalmologicals → S01C Antiinflammatory agents and antiinfectives in combination → S01CA Corticosteroids and antiinfectives in combination
Discover more medicines within S01CA01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1792920
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 85248
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 190519
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-946413615
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1090879
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100420822
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W67119001